Revolka
Sendai, Japan
RevolKa Ltd. is a pioneering company in next-generation protein engineering, committed to the discovery and development of innovative proteins through its proprietary technology called ai Protein®. This artificial intelligence-integrated directed protein evolution technology accelerates the molecular evolution of proteins, enabling the creation of unprecedented engineered proteins. RevolKa focuses on therapeutic programs, including those for rare diseases, through research collaborations, like those established with Daiichi Sankyo. The company is at the forefront of combining advanced biopharmaceutical methods with digital innovation to advance drug discovery and therapeutic developments.
Company Info
- Founded
- 2021
- Website
- www.revolka.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Revolka?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.